Global Breast Biopsy Market
Medical Equipment

Breast Biopsy Market Trends Driving Growth Through 2030

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Much Will The Market Value Of The Breast Biopsy Market Grow Between 2026 And 2030?

The breast biopsy market size has experienced substantial growth in recent years. This market is anticipated to expand from $1.53 billion in 2025 to $1.65 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.5%. The historical period’s expansion can be attributed to several factors, including the limited availability of advanced biopsy systems, reliance on traditional surgical biopsy methods, an increasing incidence of breast cancer, the development of hospital and diagnostic center infrastructure, and the adoption of ultrasound-guided procedures.

The breast biopsy market is projected to experience substantial expansion in the coming years. Its valuation is anticipated to reach $2.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.2%. This projected growth is driven by several factors, including ongoing technological progress in liquid biopsy and imaging-guided systems, increased awareness regarding the early identification of breast cancer, the proliferation of diagnostic centers and hospitals, the growing adoption of AI and data analytics, and the evolution of personalized and precision medicine strategies. Key trends anticipated during this period encompass a greater acceptance of minimally invasive biopsy techniques, the increasing application of liquid biopsy methods, advancements in imaging-guided biopsy systems, the broadening scope of breast cancer diagnostic and screening initiatives, and a heightened emphasis on ensuring patient safety and sample precision.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19348&type=smp

Which Important Drivers Are Guiding The Breast Biopsy Market Growth?

The increasing incidence of breast cancer is anticipated to drive the expansion of the breast biopsy market in the future. Breast cancer refers to a malicious tumor originating in breast tissue cells, capable of metastasizing to other bodily regions if not addressed swiftly. Its widespread occurrence is linked to elements like extended lifespans, enhanced diagnostic techniques, and greater public understanding of the condition. To diagnose and characterize breast cancer, a breast biopsy procedure collects tissue specimens from questionable breast regions. For example, in October 2025, Breastcancer.org, a US-based non-profit organization, indicated that an estimated 316,950 women are projected to receive a diagnosis of invasive breast cancer in 2025, alongside approximately 59,080 new cases of non-invasive ductal carcinoma in situ (DCIS). Consequently, the rising prevalence of breast cancer is fueling the expansion of the breast biopsy market.

How Is The Breast Biopsy Market Categorized Across Its Segment Groups?

The breast biopsy market covered in this report is segmented –

1) By Type: Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Other Types

2) By Image Guided Technology: Magnetic Resonance Imaging (MRI) Guided Breast Biopsy, Ultrasound Guided Breast Biopsy, Mammography Guided Stereotactic Biopsy, Computed Tomography (CT) Guided Biopsy, Other Image Guided Technologies

3) By Procedure: Needle Breast Biopsy, Open Surgical Breast Biopsy, Liquid Breast Biopsy

4) By Application: Hospitals, Clinics, Diagnostic Centers, Other Applications

Subsegments:

1) By Biopsy Needles: Core Biopsy Needles, Fine Needle Aspiration (FNA) Needles, Vacuum-Assisted Biopsy Needles, Automatic Biopsy Needles

2) By Guidance Systems: Ultrasound Guidance Systems, MRI Guidance Systems, Stereotactic Guidance Systems, Tomosynthesis Guidance Systems

3) By Biopsy Tables: Adjustable Biopsy Tables, Specialty Biopsy Tables, Imaging-Compatible Biopsy Tables

4) By Localization Wires: Hookwire Localization Devices, Radioguided Localization Wires, Magnetic Seed Localization Systems

5) By Assay Kits: Breast Cancer Assay Kits, Biomarker Detection Kits, Genetic Testing Kits for Breast Cancer

6) By Liquid Biopsy Instruments: Circulating Tumor Cell (CTC) Isolation Devices, Plasma DNA Isolation Kits, Liquid Biopsy Analysis Systems

7) By Other Types: Biopsy Adhesives, Specimen Collection and Transport Devices, Patient Management Systems

What Trends Are Influencing The Evolution Of The Breast Biopsy Market?

Leading companies operating in the breast biopsy marker market are concentrating on developing innovative products, such as ultrasound-visible site markers, to enhance lesion localization and reduce marker displacement during breast biopsy procedures. An ultrasound-visible site marker is a specially designed implantable device that improves visualization of biopsy sites during imaging and provides stable localization for future surgical intervention. For instance, in August 2023, Mammotome, a US-based provider of breast biopsy and localization technologies, launched HydroMark Plus. This new breast biopsy site marker offers improved lesion visibility on ultrasound, which assists radiologists and surgeons in accurately targeting biopsy sites while reducing the risk of marker displacement during subsequent surgical procedures. As the latest addition to Mammotome’s HydroMark portfolio, HydroMark Plus is designed for enhanced procedural reliability and is slated for nationwide availability in the U.S. by the end of the year. The product’s key features include high ultrasound conspicuity for easy detection, minimized risk of movement within breast tissue, and suitability for a wide variety of breast imaging and interventional workflows. These attributes are aimed at improving clinical outcomes and procedural confidence for both physicians and patients.

Which Firms Are Influencing Competition In The Breast Biopsy Market?

Major companies operating in the breast biopsy market are Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton Dickinson and Company BD, Koninklijke Philips, GE HealthCare Technologies Inc, Hologic Inc, Merit Medical Systems, Argon Medical Devices, Canon Medical Systems Corporation, Devicor Medical Products Inc, Planmed Oy, Menarini-Silicon Biosystems, Seno Medical Instruments Inc, Dilon Technologies Inc, INRAD Inc, Promaxo Inc, Cook Medical LLC, Boston Scientific Corporation, Stryker Corporation, Intact Medical Corporation, Scion Medical Technologies LLC, Galini SRL, Ethicon Surgical Technologies, Encapsule Medical Devices LLC, Cardinal Health Inc, Olympus Corporation, F Hoffmann-La Roche Ltd, Biocept Inc.

Get The Full Breast Biopsy Market Report:

https://www.thebusinessresearchcompany.com/report/breast-biopsy-global-market-report

Which Region Is The Largest In The Breast Biopsy Market?

North America was the largest region in the breast biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breast biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Breast Biopsy Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=19348&type=smp

Browse Through More Reports Similar to the Global Breast Biopsy Market 2026, By The Business Research Company

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Liquid Biopsy For Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Smart Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model